Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (101)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boelaert, J. R.
Right arrow Articles by Herwaldt, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boelaert, J. R.
Right arrow Articles by Herwaldt, L. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1993) 8: 235-239
© 1993 European Renal Association-European Dialysis and Transplant Association


research-article

Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients

J. R. Boelaert1,, H. W. Van Landuyt2, C. A. Godard3, R. F. Daneels1, M. L. Schurgers1, E. G. Matthys1, Y. A. De Baere1, D. W. Gheyle1, B. Z. Gordts2 and L. A. Herwaldt4

1Unit for Renal and Infectious Diseases, Algemeen Ziekenhuis Sint Jan Brugge, Belgium 2Department of Microbiology, Algemeen Ziekenhuis Sint Jan Brugge, Belgium 3Institut Pasteur du Brabant Bruxelles, Belgium 4Division of General Medicine, Clinical Epidemiology and Health Services Research, University of Iowa Hospitals and Clinics Iowa City, Iowa, USA

Correspondence and offprint requests to: Correspondence and offprint requests to: Dr J. R. Boelaert, Unit for Renal and Infectious Diseases, Algemeen Ziekenhuis Sint-Jan, B-8000 Brugge, Belgium

The incidence of S. aureus bacteraemia in a haemodialysis unit was studied over 2 years (167.75 patient-years of follow-up) during which nasal calcium mupirocin was used to eradicate nasal S. aureus carriage; this incidence was compared to that previously observed in the same unit before the use of nasal mupirocin (185.8 patient-years). Nasal mupirocin led to eradication of nasal S. aureus carriage in 96.3% of surveillance cultures and to a fourfold reduction in the incidence of S. aureus bacteraemia per patient-year, from 0.097 before mupirocin to 0.024 with mupirocin use (P=0.008). Once or thrice weekly maintenance regimens of mupirocin were equally efficacious. The incidence of bacteraemia caused by other microorganisms was not significantly affected. One single mupirocin-resistant isolate was identified in a nasal surveillance culture. Eradication of S. aureus from the nares did not lead to overgrowth by other microorganisms. Chemoprophylaxis with nasal mupirocin in haemodialysis patients is cost-effective.

Keywords: bacteraemia; haemodialysis; infection; mupirocin; nasal carriage; Staphylococcus aureus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
G. A. Noskin, R. J. Rubin, J. J. Schentag, J. Kluytmans, E. C. Hedblom, M. Smulders, E. Lapetina, and E. Gemmen
The Burden of Staphylococcus aureus Infections on Hospitals in the United States: An Analysis of the 2000 and 2001 Nationwide Inpatient Sample Database
Arch Intern Med, August 8, 2005; 165(15): 1756 - 1761.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Hoen
Infective endocarditis: a frequent disease in dialysis patients
Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1360 - 1362.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. J. Peacock, A. Justice, D. Griffiths, G. D. I. de Silva, M. N. Kantzanou, D. Crook, K. Sleeman, and N. P. J. Day
Determinants of Acquisition and Carriage of Staphylococcus aureus in Infancy
J. Clin. Microbiol., December 1, 2003; 41(12): 5718 - 5725.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
A. F. Schild, S. Simon, J. Prieto, and J. Raines
Single-Center Review of Infections Associated with 1,574 Consecutive Vascular Access Procedures
Vascular and Endovascular Surgery, January 1, 2003; 37(1): 27 - 31.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. E. Lok, K. E. Stanley, J. E. Hux, R. Richardson, S. W. Tobe, and J. Conly
Hemodialysis Infection Prevention with Polysporin Ointment
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 169 - 179.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. W. Johnson, R. MacGinley, T. D. Kay, C. M. Hawley, S. B. Campbell, N. M. Isbel, and P. Hollett
A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters
Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1802 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
V. Mickley
Central venous catheters: many questions, few answers
Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1368 - 1373.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. K. Dogra, H. Herson, B. Hutchison, A. B. Irish, C. H. Heath, C. Golledge, G. Luxton, and H. Moody
Prevention of Tunneled Hemodialysis Catheter-Related Infections Using Catheter-Restricted Filling with Gentamicin and Citrate: A Randomized Controlled Study
J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2133 - 2139.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. M. Perl, J. J. Cullen, R. P. Wenzel, M. B. Zimmerman, M. A. Pfaller, D. Sheppard, J. Twombley, P. P. French, L. A. Herwaldt, and the Mupirocin and the Risk of Staphylococcus aureu
Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections
N. Engl. J. Med., June 13, 2002; 346(24): 1871 - 1877.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
S.J. Peacock, S. Mandal, and I.C.J.W. Bowler
Preventing Staphylococcus aureus infection in the renal unit
QJM, June 1, 2002; 95(6): 405 - 410.
[Full Text] [PDF]


Home page
NEJMHome page
C. von Eiff, K. Becker, K. Machka, H. Stammer, and G. Peters
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
N. Engl. J. Med., January 4, 2001; 344(1): 11 - 16.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. B. Kiser, J. M. Cantey-Kiser, and J. C. Lee
Development and Characterization of a Staphylococcus aureus Nasal Colonization Model in Mice
Infect. Immun., October 1, 1999; 67(10): 5001 - 5006.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. H. Nguyen, C. A. Kauffman, R. P. Goodman, C. Squier, R. D. Arbeit, N. Singh, M. M. Wagener, and V. L. Yu
Nasal Carriage of and Infection with Staphylococcus aureus in HIV-Infected Patients
Ann Intern Med, February 2, 1999; 130(3): 221 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Ruef, S. Fanconi, and D. Nadal
STERNAL WOUND INFECTION AFTER HEART OPERATIONS IN PEDIATRIC PATIENTS ASSOCIATED WITH NASAL CARRIAGE OF STAPHYLOCOCCUS AUREUS
J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 681 - 686.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.